Big Tech Reports… And Eli Lilly’s Letdown 10/30/24
CNBC's "Fast Money"
Intro
This chapter analyzes recent earnings reports from major companies, emphasizing Meta's strong performance and Eli Lilly's challenges with GLP-1 drugs. It also addresses Supermicro's issues with its auditor, raising questions about its future stability.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
